Detalles de la búsqueda
1.
Health-related quality of life in patients with ß-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept.
Eur J Haematol
; 111(1): 113-124, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095595
2.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
BMC Cancer
; 21(1): 642, 2021 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051732
3.
Bayesian Latent Class Analysis Tutorial.
Multivariate Behav Res
; 53(3): 430-451, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29424559
4.
Optimism, social support, and mental health outcomes in patients with advanced cancer.
Psychooncology
; 23(3): 299-306, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24123339
5.
Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials.
JNCI Cancer Spectr
; 7(2)2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661326
6.
Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial.
Hemasphere
; 7(3): e843, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860268
7.
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial.
Eur J Cancer
; 187: 164-173, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37167764
8.
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia.
BMJ Open
; 13(3): e066683, 2023 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948565
9.
Luspatercept for the treatment of anaemia in non-transfusion-dependent ß-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Lancet Haematol
; 9(10): e733-e744, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36007538
10.
Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial.
J Clin Med
; 11(1)2021 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011768
11.
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA Trial.
Hemasphere
; 5(5): e553, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33969273
12.
Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial.
Hemasphere
; 5(5): e562, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33969275
13.
Abstract: Extraction of Latent Class Progressions in Behavioral Data.
Multivariate Behav Res
; 50(1): 140, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26609758
14.
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial.
J Clin Oncol
; 37(11): 867-875, 2019 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30811280
15.
Promoting cancer prevention and control in community-based HIV/AIDS service organizations: are they ready?
AIDS Educ Prev
; 26(1): 43-55, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24450277
16.
Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer.
Health Psychol
; 33(7): 737-47, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23895203
Resultados
1 -
16
de 16
1
Próxima >
>>